![Scanning electron micrograph of Mycobacterium tuberculosis bacteria, which cause TB. Image by National Institute of Allergy and Infectious Diseases, National Institutes of Health Scanning electron micrograph of Mycobacterium tuberculosis bacteria, which cause TB. Image by National Institute of Allergy and Infectious Diseases, National Institutes of Health](/sites/default/files/styles/project_teaser_image/public/uploads/Newsroom%20images/MycobacteriumTuberculosis_NationalInstituteOfAllergyAndInfectiousDiseases_NationalInstitutesOfHealth.jpg?itok=1UPjEpIe)
IMI tuberculosis project TRIC-TB is using a novel approach to boost the efficacy of existing TB drugs.
IMI tuberculosis project TRIC-TB is using a novel approach to boost the efficacy of existing TB drugs.
Projects can often help each other reach their goals, as demonstrated by the IMI projects IMI-PainCare and EQIPD. Together, they are helping to bring better approaches for those...
Through the States Representatives Group (SRG), Member States provide vital input into the direction of IHI, as SRG chair Martha Cahill explains in this interview.
The joint undertakings are about creating public-private partnerships (PPPs) – and IHI is no exception. In an interview, the European Commission’s Irene Norstedt, chair of the...
The Innovative Health Initiative (IHI) has launched its first calls for proposals, with topics on diseases such as cancer, cardiovascular disease and neurodegenerative diseases, as...
IHI call 2 is a two-stage call with topics on cardiovascular disease and early feasibility studies.
IHI call 1 was a single-stage call with topics on cancer, neurodegenerative diseases, and health data.
Guidance, templates and links for people planning on applying to be part of an IHI project.